Neonatal status epilepticus vs recurrent neonatal seizures: Clinical findings and outcome

Neurology ◽  
2007 ◽  
Vol 69 (23) ◽  
pp. 2177-2185 ◽  
Author(s):  
F. Pisani ◽  
C. Cerminara ◽  
C. Fusco ◽  
L. Sisti
1994 ◽  
Vol 52 (2) ◽  
pp. 260-262 ◽  
Author(s):  
José Luiz Dias Gherpelli ◽  
Francisco José C. Luccas ◽  
Israel Roitman ◽  
Eduardo Juan Troster

Midazolam is a short-acting water soluble benzodiazepine that has been used with an increasing frequency in the last years. Although there are reports on its use in status epilepticus, there is none in the neonatal period. A pre-term (35 w) AGA newborn infant with a severe hypoxic-ischemic encephalopathy secondary to grade ED hyaline membrane disease developed status epilepticus in the first 6 hours of life and was successfully treated with midazolam after phenobarbital and phenytoin failed to achieve seizure control. Dosage schedule was 0.2 mg/kg IV, followed by continuous infusion of 0.025 mg/kg/h. Midazolam is an effective drug for neonatal status epilepticus and more experience should accumulate before it can be routinely employed in the neonatal period. This case shows that it is a possible option before using more dangerous drugs, such as thionembutal.


2012 ◽  
Vol 29 (5) ◽  
pp. 441-448 ◽  
Author(s):  
Nicholas S. Abend ◽  
Courtney J. Wusthoff

2015 ◽  
Vol 02 (02) ◽  
pp. 084-086 ◽  
Author(s):  
Aastha Takkar ◽  
Manoj Goyal ◽  
Manish Modi ◽  
Parampreet Kharbanda ◽  
Lakshminarayana Yaddanapudi ◽  
...  

Abstract Background During the global H1N1 pandemic, neurological complications were reported in approximately 6–10% of children suffering from H1N1 infection, but only rarely in adults. Generalized convulsive status epilepticus (GCSE) as a presenting manifestation of H1N1 infection in an adult is exceedingly rare and has not been reported in literature. We report a patient who presented to us with GCSE as a presenting manifestation of H1N1 infection who improved following appropriate antiviral treatment. Methods and results This 20-year-old gentleman presented to us with history of fever followed by GCSE of 24 h duration. He was treated symptomatically and was evaluated in detail. He was diagnosed to be suffering from H1N1 infection based on appropriate serological tests. After start of antiviral therapy, he improved and is doing well at 4 months follow up. Conclusion This case report further expands the spectrum of clinical findings associated with sporadic H1N1 infection. A possibility of H1N1 infection should be considered in all patients who present with GCSE without any obvious cause so that appropriate diagnostic tests and treatment can be carried out at the earliest.


2019 ◽  
Vol 6 (6) ◽  
pp. 2678
Author(s):  
Imella Marcos ◽  
Darto Saharso ◽  
Prastiya Indra Gunawan

Benign neonatal sleep myoclonus (BNSM), is a disorder generally mistaken for seizures during the newborn period. Benign neonatal sleep myoclonus is featured by myoclonic "lightninglike" jerks of the extremities that exclusively occur during sleep; it is not associated with epilepsy that occur only during sleep and cease abruptly when the child is agitated. This case reported was a 50 days-old baby boy with a history suggestive of abnormal movements for limbs noted over the preceding 7 days. Diagnosis of BNSM in infant based on history taking, clinical manifestation, and with no electroencephalographic changes. BNSM is usually not associated with any other neurologic impairment and spontaneously subsides within the first year of life. Its importance lies in the differential diagnosis with the epileptic, especially myoclonic, seizures of infancy. BNSM can be misinterpreting for neonatal seizures or even neonatal status epilepticus, the recognition of benign sleep myoclonus of infancy is imperative to elude unnecessary diagnostic studies and treatments.


Sign in / Sign up

Export Citation Format

Share Document